NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Apparently many people think going after one thing, like with blood cancer, is worth an awful lot - if you look at KITE and previously JUNO valuations. Even Celldex only went after one thing... and when it was done, EGFRv3 was gone. Of course, the GBM still came back, just sans that.

And yet, here's little old DCVax armed to go after all the antigens on whatever tumor used to make it... and NWBO sits at .18¢.

It's just unbelievable. I honestly just don't think the general market gets how it all works. And I think those who do get it, and are not invested, are counting on that.